← Back to headlines
Eupraxia Pharmaceuticals Stock Falls After Public Offering
Eupraxia Pharmaceuticals' stock declined following the pricing of its $55 million public offering.
19 Feb, 10:44 — 19 Feb, 10:44
Eupraxia Pharmaceuticals' stock declined following the pricing of its $55 million public offering.
19 Feb, 10:44 — 19 Feb, 10:44
